GLOBAL PROTEOMICS MARKET FORECAST 2019-2027

  • You are here:
  • Home
  • Reports
  • GLOBAL PROTEOMICS MARKET FORECAST 2019-2027

GLOBAL PROTEOMICS MARKET FORECAST 2019-2027

The global proteomics market is anticipated to generate revenue of $58.3 billion by 2027 and to grow at a CAGR of 14.68% between 2019 and 2027. Proteomics has the capacity to answer questions that remain unsolved in the field of genomics, as in the field of proteomics, the proteins are considered to be the functional unit of cells, instead of the nucleic acids.

GLOBAL PROTEOMICS MARKET FORECAST 2019-2027

Global Proteomics Market by Application (Drug Discovery, Disease Diagnosis, Other Application) by Component (Reagents, Instruments, Chromatography, Services) by End-user (Drug Discovery and Development, Applied, Research, Diagnostics) by Geography.

Request free sample

The global proteomics market is anticipated to generate revenue of $58.3 billion by 2027 and to grow at a CAGR of 14.68% between 2019 and 2027. Proteomics has the capacity to answer questions that remain unsolved in the field of genomics, as in the field of proteomics, the proteins are considered to be the functional unit of cells, instead of the nucleic acids. The proteomics market is primarily driven by the following factors:

  • Advancement in proteomic technologies
  • Increase in R&D expenditure
  • Technological advancements
  • The increasing use of proteomics information

The important drivers that are increasing the growth of the global proteomics market are the advancement in proteomic technologies and increasing use of proteomics information. Advances in proteomic technologies have made an important contribution to the development of personalized medicine by facilitating the detection of protein biomarkers, proteomics-based molecular diagnostics, as well as protein biochips and pharmaco-proteomics. Proteomics information can complement genomics data to help drug researchers better understand how the underlying biologics of system function.

The applications and components of proteomics market are used extensively for various purposes. Proteomics is used for the discovery of new antimalarial drugs that target purine-binding proteins in the blood stage of infection. The drug discovery workflow uses numerous biochemical and genetic assays to assess the effect of a candidate drug molecule on cellular systems and model organisms. Proteomics finds extensive application in the diagnosis of tumor metastasis and renal diseases. The identification of disease-associated biomarkers is vital for the diagnosis and treatment of kidney disease. The other applications include fetal & maternal medicine, autoantibody profiling for the study & treatment of autoimmune disease. Reagents are used in proteomics to convert extracellular signals into intracellular signals in cellular processes. Large research centers employ HPLC or gas chromatography along with mass spectroscopy and NMR analysis. These types of instruments can be used for the process of proteomics. Proteomics services are widely used across laboratory and research facilities for diagnosis of diseases.

High cost of instruments is one of the major factors that is hindering the proteomics market growth. The high price of instruments and reagents makes it difficult for emerging countries to venture in the field of proteomics. Besides, the outcome of the study and trials is not always as per expectation, and the results obtained may not be satisfactory. Hence, the high cost of instruments restrict the market growth.

The global proteomics market segments include component, application, and end-user.

Component is sub-segmented into:

    • Reagents
      • Microarray
      • Spectroscopy
      • X-ray crystallography
      • Chromatography
      • Electrophoresis
      • Immunoassay
      • Protein fractionation reagents
    • Instruments
      • Microarray
      • Spectroscopy
        • Mass spectrometry
        • NMR spectrometry
    • Chromatography
      • HPLC systems
      • Ion chromatography
      • Affinity chromatography
      • Supercritical fluid chromatography
  • Services

Applications are sub-segmented into:

  • Drug discovery
  • Disease diagnosis
  • Other application

End Users are sub-segmented into:

  • Drug discovery and development
  • Applied
  • Research
  • Diagnostics

This report covers the present market conditions and the growth prospects of the global proteomics market for 2019-2027 and considered the revenue generated through the sales of proteomics for the component, application, and end-user to calculate the market size by considering 2018 as the base year.

Geographically, the global proteomics market has been segmented on the basis of four major regions, which include:

The proteomics market in North America is expected to hold the largest share by 2027 possibilities of increased use of proteomics. North America proteomics market constitutes approximately 40% of the market share. The U.S. proteomics market is expected to account for the majority of the share in the global market. A large number of significant developments have shaped the North America proteomics industry. Proteomics research received a major boost in Canada, owing to the funding support by a government organization.

On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the proteomics market. Japan was the highest contributor to the Asia-Pacific market. Japan has a growing life sciences research infrastructure that is increasing market growth. Numerous private companies and government organizations, like Celera Genomics, and analytical and pharmaceutical instrumental companies have significantly invested in the human proteome project.

The proteomics market is segmented based on end-user which is sub-divided into drug discovery and development, applied, research, and diagnostics. The drug discovery and development market consist of pharmaceuticals, biopharmaceuticals, biotechnology, generic and contract research organization (CRO) customers.

Applied markets include forensics, environmental and agricultural sectors. Proteomics is important in environmental applications to study bacterial physiology, metabolism, and ecology. Research institutions continue to play an important role in developing and proving out innovative technologies in the fields of mass spectrometry and biochips which is boosting the proteomics market growth. Diagnostics include the introduction of innovative MS instrument workflows and FDA registrations for clinical applications, and growth in proteomic cancer applications.

The major market players of the global proteomics market are:

  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies Inc.
  • Waters Corporation
  • PerkinElmer, Inc.
  • Bruker Corporation

Company profiles covers the analysis of important players. Thermo Fisher Scientific Inc., formed in 2006 from a merger between Thermo Electron and Fisher Scientific, develops and markets life science and laboratory analytical instruments, equipment, reagents, and software. Bruker is a leading manufacturer of mass spectrometry instruments and consumables. Bruker BioSpin manufactures products based on magnetic resonance core technology, including nuclear magnetic resonance (NMR), preclinical magnetic resonance imaging (MRI) and electron paramagnetic resonance (EPR).

Key Findings of the global proteomics market:

  • Reagents are the widely used proteomics component
  • Disease diagnosis is the fastest growing application
  • Drug discovery and development is the majorly used end-user
  1. RESEARCH SCOPE
    • STUDY GOALS
    • SCOPE OF THE MARKET STUDY
    • WHO WILL FIND THIS REPORT USEFUL?
    • STUDY AND FORECASTING YEARS
  2. RESEARCH METHODOLOGY
    • SOURCES OF DATA
      • SECONDARY DATA
      • PRIMARY DATA
    • TOP-DOWN APPROACH
    • BOTTOM-UP APPROACH
    • DATA TRIANGULATION
  3. EXECUTIVE SUMMARY
    • MARKET SUMMARY
    • KEY FINDINGS
      • REAGENTS ARE THE WIDELY USED PROTEOMICS COMPONENT
      • DISEASE DIAGNOSIS IS THE FASTEST GROWING APPLICATION
      • DRUG DISCOVERY AND DEVELOPMENT IS THE MAJORLY USED END-USER
  1. MARKET DETERMINANTS
    • MARKET SCOPE & DEFINITION
    • MARKET DRIVERS
      • ADVANCEMENT IN PROTEOMIC TECHNOLOGIES
      • INCREASE IN R&D EXPENDITURE
      • TECHNOLOGICAL ADVANCEMENTS
      • INCREASING USE OF PROTEOMICS INFORMATION
    • MARKET RESTRAINTS
      • HIGH COST OF INSTRUMENTS
    • MARKET OPPORTUNITIES
      • IDENTIFICATION OF NOVEL BIOMARKERS
      • WIDESPREAD USE OF MASS SPECTROMETER TO STUDY PROTEIN-PROTEIN INTERACTION
    • MARKET CHALLENGES
      • LACK OF SKILLED PROFESSIONALS
      • STRINGENT REGULATIONS
  1. MARKET BY APPLICATION
    • DRUG DISCOVERY
    • DISEASE DIAGNOSIS
    • OTHER APPLICATION
  2. MARKET BY COMPONENT
    • REAGENTS
      • MICROARRAY
      • SPECTROSCOPY
      • X-RAY CRYSTALLOGRAPHY
      • CHROMATOGRAPHY
      • ELECTROPHORESIS
      • IMMUNOASSAY
      • PROTEIN FRACTIONATION REAGENTS
    • INSTRUMENTS
      • MICROARRAY
      • SPECTROSCOPY
        • MASS SPECTROMETRY
        • NMR SPECTROMETRY
      • CHROMATOGRAPHY
        • HPLC SYSTEMS
        • ION CHROMATOGRAPHY
        • AFFINITY CHROMATOGRAPHY
        • SUPERCRITICAL FLUID CHROMATOGRAPHY
      • SERVICES
  1. MARKET BY END-USER
    • DRUG DISCOVERY AND DEVELOPMENT
    • APPLIED
    • RESEARCH
    • DIAGNOSTICS
  2. KEY ANALYTICS
    • PORTER’S FIVE FORCES MODEL
      • THREAT OF NEW ENTRANTS
      • THREAT OF SUBSTITUTE
      • BARGAINING POWER OF BUYERS
      • BARGAINING POWER OF SUPPLIERS
      • THREAT OF COMPETITIVE RIVALRY
    • PROTEOMICS INDUSTRY ANALYSIS
    • APPLICATIONS OF PROTEOMIC IN DRUG DISCOVERY AND DEVELOPMENT
    • SCIENTIFIC INITIATIVES IN PROTEOMICS
    • PATENT ANALYSIS
    • OPPORTUNITY MATRIX
  3. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA
  1. COMPETITIVE LANDSCAPE
    • MARKET POSITION ANALYSIS
    • COMPANY PROFILES
      • AGILENT TECHNOLOGIES, INC.
      • BIO-RAD LABORATORIES, INC.
      • BRUKER CORPORATION
      • CAPRION BIOSCIENCES (ACQUIRED BY GHO CAPITAL)
      • DANAHER CORPORATION
      • GENERAL ELECTRIC COMPANY
      • GLAXOSMITHKLINE
      • HORIBA, LTD.
      • LI-COR INC.
      • LUMINEX CORP.
      • MERCK & COMPANY INC.
      • PERKINELMER, INC.
      • QIAGEN N.V.
      • THERMO FISHER SCIENTIFIC INC.
      • WATERS CORPORATION

LIST OF TABLES

TABLE 1        GLOBAL PROTEOMICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 2        GLOBAL PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 3        GLOBAL DRUG DISCOVERY MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 4        GLOBAL DISEASE DIAGNOSIS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 5        GLOBAL OTHER APPLICATION MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 6        GLOBAL PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 7        GLOBAL REAGENTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 8        GLOBAL REAGENTS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 9        GLOBAL INSTRUMENTS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 10      GLOBAL INSTRUMENTS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 11      GENERAL WORKFLOW OF MASS SPECTROMETRY (MS)

TABLE 12      GLOBAL SERVICES MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 13      GLOBAL PROTEOMICS MARKET BY END-USER 2019-2027 ($ MILLION)

TABLE 14      GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 15      GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET BY BIOCHIP PLATFORM 2019-2027 ($ MILLION)

TABLE 16      GLOBAL RESEARCH MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 17      GLOBAL BIOCHIP MARKET BY PLATFORM 2019-2027 ($ MILLION)

TABLE 18      GLOBAL DIAGNOSTICS MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 19      GLOBAL BIOCHIP MARKET BY TYPE 2019-2027 ($ MILLION)

TABLE 20      GLOBAL DIAGNOSTICS MARKET BY DISEASE TYPE 2019-2027 ($ MILLION)

TABLE 21      GLOBAL DISEASE TYPE MARKET BY CANCER 2019-2027 ($ MILLION)

TABLE 22      STATUS OF THE MAJOR PROTEOMICS INDUSTRIES

TABLE 23      ARRAY-RELATED PROTEOMICS PATENTS BY REGION 2015–2018 (%)

TABLE 24      LOC-RELATED PROTEOMICS PATENTS BY REGION 2015-2018 (%)

TABLE 25      MASS SPECTROMETRY-RELATED PROTEOMICS PATENTS BY REGION 2015-2018 (%)

TABLE 26      GLOBAL PROTEOMICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 27      NORTH AMERICA PROTEOMICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 28      THE UNITED STATES PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 29      THE UNITED STATES PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 30      CANADA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 31      CANADA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 32      EUROPE PROTEOMICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 33      GERMANY PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 34      GERMANY PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 35      FRANCE PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 36      FRANCE PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 37      THE UNITED KINGDOM PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 38      THE UNITED KINGDOM PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 39      ITALY PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 40      ITALY PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 41      SPAIN PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 42      SPAIN PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 43      ASIA PACIFIC PROTEOMICS MARKET BY COUNTRY 2019-2027 ($ MILLION)

TABLE 44      JAPAN PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 45      JAPAN PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 46      CHINA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 47      CHINA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 48      INDIA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 49      INDIA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 50      AUSTRALIA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 51      AUSTRALIA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 52      SOUTH KOREA PROTEOMICS MARKET BY COMPONENT 2019-2027 ($ MILLION)

TABLE 53      SOUTH KOREA PROTEOMICS MARKET BY APPLICATION 2019-2027 ($ MILLION)

TABLE 54      REST OF WORLD PROTEOMICS MARKET BY REGION 2019-2027 ($ MILLION)

TABLE 55      PROTEOMICS COMPANY MARKET POSITION ANALYSIS 2017

FIGURE LIST

FIGURE 1      GLOBAL PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 2      GLOBAL PROTEOMICS MARKET SHARE BY APPLICATION 2018 & 2027 (%)

FIGURE 3      GLOBAL PROTEOMICS MARKET BY DRUG DISCOVERY 2019-2027 ($ MILLION)

FIGURE 4      GLOBAL PROTEOMICS MARKET BY DISEASE DIAGNOSIS 2019-2027 ($ MILLION)

FIGURE 5      GLOBAL PROTEOMICS MARKET BY OTHER APPLICATION 2019-2027 ($ MILLION)

FIGURE 6      GLOBAL PROTEOMICS MARKET SHARE BY COMPONENT 2018 & 2027 (%)

FIGURE 7      GLOBAL PROTEOMICS MARKET BY REAGENTS 2019-2027 ($ MILLION)

FIGURE 8      GLOBAL REAGENTS MARKET BY MICROARRAY 2019-2027 ($ MILLION)

FIGURE 9      GLOBAL REAGENTS MARKET BY SPECTROSCOPY 2019-2027 ($ MILLION)

FIGURE 10   GLOBAL REAGENTS MARKET BY X-RAY CRYSTALLOGRAPHY 2019-2027 ($ MILLION)

FIGURE 11   GLOBAL REAGENTS MARKET BY CHROMATOGRAPHY 2019-2027 ($ MILLION)

FIGURE 12   GLOBAL REAGENTS MARKET BY ELECTROPHORESIS 2019-2027 ($ MILLION)

FIGURE 13   GLOBAL REAGENTS MARKET BY IMMUNOASSAY 2019-2027 ($ MILLION)

FIGURE 14   GLOBAL REAGENTS MARKET BY PROTEIN FRACTIONATION REAGENTS 2019-2027 ($ MILLION)

FIGURE 15   GLOBAL PROTEOMICS MARKET BY INSTRUMENTS 2019-2027 ($ MILLION)

FIGURE 16   GLOBAL INSTRUMENTS MARKET BY MICROARRAY 2019-2027 ($ MILLION)

FIGURE 17   GLOBAL INSTRUMENTS MARKET BY SPECTROSCOPY 2019-2027 ($ MILLION)

FIGURE 18   GLOBAL SPECTROSCOPY MARKET BY MASS SPECTROMETRY 2019-2027 ($ MILLION)

FIGURE 19   GLOBAL SPECTROSCOPY MARKET BY NMR SPECTROMETRY 2019-2027 ($ MILLION)

FIGURE 20   GLOBAL INSTRUMENTS MARKET BY CHROMATOGRAPHY 2019-2027 ($ MILLION)

FIGURE 21   GLOBAL CHROMATOGRAPHY MARKET BY HPLC SYSTEMS 2019-2027 ($ MILLION)

FIGURE 22   GLOBAL CHROMATOGRAPHY MARKET BY ION CHROMATOGRAPHY 2019-2027 ($ MILLION)

FIGURE 23   GLOBAL CHROMATOGRAPHY MARKET BY AFFINITY CHROMATOGRAPHY 2019-2027 ($ MILLION)

FIGURE 24   GLOBAL CHROMATOGRAPHY MARKET BY SUPERCRITICAL FLUID CHROMATOGRAPHY 2019-2027 ($ MILLION)

FIGURE 25   GLOBAL PROTEOMICS MARKET BY SERVICES 2019-2027 ($ MILLION)

FIGURE 26   GLOBAL PROTEOMICS MARKET SHARE BY END-USER 2018 & 2027 (%)

FIGURE 27   GLOBAL PROTEOMICS MARKET BY DRUG DISCOVERY AND DEVELOPMENT 2019-2027 ($ MILLION)

FIGURE 28   GLOBAL PROTEOMICS MARKET BY APPLIED 2019-2027 ($ MILLION)

FIGURE 29   GLOBAL PROTEOMICS MARKET BY RESEARCH 2019-2027 ($ MILLION)

FIGURE 30   GLOBAL PROTEOMICS MARKET BY DIAGNOSTICS 2019-2027 ($ MILLION)

FIGURE 31   PORTER’S FIVE FORCE MODEL

FIGURE 32   GLOBAL PROTEOMICS MARKET REGIONAL OUTLOOK 2018 & 2027 (%)

FIGURE 33   THE UNITED STATES PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 34   CANADA PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 35   GERMANY PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 36   FRANCE PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 37   THE UNITED KINGDOM PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 38   ITALY PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 39   SPAIN PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 40   REST OF EUROPE PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 41   JAPAN PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 42   CHINA PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 43   INDIA PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 44   AUSTRALIA PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 45   SOUTH KOREA PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 46   REST OF ASIA-PACIFIC PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 47   LATIN AMERICA PROTEOMICS MARKET 2019-2027 ($ MILLION)

FIGURE 48   MIDDLE EAST AND AFRICA PROTEOMICS MARKET 2019-2027 ($ MILLION)

  1. MARKET BY APPLICATION
    • DRUG DISCOVERY
    • DISEASE DIAGNOSIS
    • OTHER APPLICATION
  2. MARKET BY COMPONENT
    • REAGENTS
      • MICROARRAY
      • SPECTROSCOPY
      • X-RAY CRYSTALLOGRAPHY
      • CHROMATOGRAPHY
      • ELECTROPHORESIS
      • IMMUNOASSAY
      • PROTEIN FRACTIONATION REAGENTS
    • INSTRUMENTS
      • MICROARRAY
      • SPECTROSCOPY
        • MASS SPECTROMETRY
        • NMR SPECTROMETRY
      • CHROMATOGRAPHY
        • HPLC SYSTEMS
        • ION CHROMATOGRAPHY
        • AFFINITY CHROMATOGRAPHY
        • SUPERCRITICAL FLUID CHROMATOGRAPHY
      • SERVICES
  1. MARKET BY END-USER
    • DRUG DISCOVERY AND DEVELOPMENT
    • APPLIED
    • RESEARCH
    • DIAGNOSTICS
  2. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • THE UNITED STATES
      • CANADA
    • EUROPE
      • GERMANY
      • FRANCE
      • THE UNITED KINGDOM
      • ITALY
      • SPAIN
      • REST OF EUROPE
    • ASIA PACIFIC
      • JAPAN
      • CHINA
      • INDIA
      • AUSTRALIA
      • SOUTH KOREA
      • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • LATIN AMERICA
      • MIDDLE EAST AND AFRICA

To request a free sample copy of this report, please complete the form below :

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

Choose License Type

Buy Now